A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Cyclophosphamide; Doxorubicin
- Indications Malignant thymoma; Thymoma
- Focus Therapeutic Use
- 05 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 05 Apr 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer